Ocular Therapeutix, Inc. ( OCUL) - Stock Earnings
OCUL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 10, 2026 AfterMarket | — / — | — | — / — | — |
OCUL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -64.7 million USD | 13.3 million USD |
| 2026Q1 | -88.6 million USD | 10.8 million USD |
| 2026Q2 | -78.8 million USD | 13.5 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
OCUL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -80.7 million USD | 58.4 million USD |
| 2024 | -193.5 million USD | 63.7 million USD |
| 2025 | -265.9 million USD | 51.8 million USD |
| 2026 Est. | — | — |
OCUL
Price: $10.04
Earnings Per Share: -1.47 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 567800
Ebitda: -14.6 millionMarket Capitalization: 2.2 billion